10.1002/ejoc.201801518
European Journal of Organic Chemistry
FULL PAPER
2
15.0 (s, CH3). 31P NMR (202 MHz, CDCl3) 112.93 (bm). GC-MS m/z (rel.
int. %): 127 [(PhPH(OH))+] (100), 126 (55), 109 (22), 95 (25), 83 (24).
Anal. Calcd for C22H38BO2P: C, 70.22; H, 10.18. Found: C, 69.95; H,
10.00.
132.0, 138.1 (s, CH, minor), 138.8 (s, CH, major), 131.2 (d, JP-C = 10.9
2
1
Hz, CH, minor), 131.0 (d, JP-C = 10.9 Hz, CH, major), 130.2 (d, JP-C
59.0 Hz, C, major), 130.2 (d, JP-C = 59.0 Hz, C, major), 128.9 (d, JP-C
=
=
1
1
57.2 Hz, C, major), 128.7, 128.5 (d, 3JP-C = 10.9 Hz, CH, major), 128.3 (d,
3JP-C = 10.0 Hz, CH, minor), 128.2 (d, JP-C = 1.8 Hz, CH), 128.18 (d, JP-C
= 3.6 Hz, CH), 128.17 (d, JP-C = 1.8 Hz, CH), 128.1 (d, JP-C = 2.7 Hz, CH),
127.95 (d, JP-C = 3.6 Hz, CH), 127.88 (d, JP-C = 2.7 Hz, CH), 127.7 (d, JP-
C. General procedurefor reduction of -amino phosphinates 19 and
-amino phosphonates 22 by BH3-SMe2. In the two-necked round-
bottom flask (25 mL) equipped with a magnetic stirrer and an argon inlet
was placed-amino phosphonate 22 (0.25 mmol) or -amino
phosphinate 19 in anhydrous THF (5 mL). Then, BH3-SMe2 (71.2 L,
0.75 mmol for 19a-b) or BH3-SMe2 (118.6 L, 1.25 mmol for 22a,c-f,
22h-k, 25) or BH3-SMe2 (0.237 mL, 2.5 mmol for 22b, 22g, 22l) was
slowly added via syringe to avoid uncontrolled bubbling. After addition of
BH3 complex the reaction mixture was stirred and heated at 60 C for
indicated time (4-24 h). Then, the reaction mixture was evaporated to
dryness and the residue was purified by column chromatography on
silica gel using hexane/AcOEt (v/v = 6:1) or hexane/AcOEt (v/v = 4:1) as
eluent.
= 2.7 Hz, CH), 115.62 (s, CH, major), 115.58 (s, CH, minor), 110.3 (s,
C, major), 110.2 (s, C, minor), 65.11 (d, JP-C = 2.7 Hz, CH2, minor),
C
2
2
1
65.01 (d, JP-C = 3.6 Hz, CH2, major), 60.7 (d, JP-C = 44.5 Hz, minor),
59.4 (d, 1JP-C = 46.3 Hz, major), 16.7 (d, 3JP-C = 6.4 Hz, CH3, minor), 16.4
(d, 3JP-C = 5.5 Hz, CH3, major). 31P NMR (202 MHz, CDCl3) 109.74 (bm,
major), 114.53 (bm, minor). HRMS (ESI/TOF) Found m/z: 428.0952;
C21H25BBrNOP ([M+H]+) requires m/z: 428.0942. Anal. Calcd for
C21H24BBrNOP: C, 58.92; H, 5.65; N, 3.27. Found: C, 58.79; H, 5.85; N,
3.10.
[1-(N-p-Bromophenylamino)]-1-phenylmethylphosphonous
acid-
borane diisopropyl ester (23a). 22a (0.107 g, 0.25 mmol) was reacted
with BH3-SMe2 (118.6 L, 1.25 mmol) for 16 h according to general
procedure C to afford 23a (0.0816 g, 0.193 mmol, 77) as an oil. Rf =
0.64 (hexane/AcOEt 10:1). IR (ATR, thin film): 3404, 2978, 2386, 1593,
[(4-Bromophenylamino)(phenyl)methyl]phenylphosphinous
acid-
borane isopropyl ester (20a). 19a (0.111 g, 0.25 mmol) was reacted
with BH3-SMe2 (71.2 L, 0.75 mmol) for 20 h according to general
procedure C to afford 20a as a mixture of diastereoisomers isolated as a
mixture (0.093 g, 0.21 mmol, 84, dr = 59:41) as an oil. Rf = 0.7
(hexane/AcOEt 6:1). IR (ATR, thin film): 3395, 2978, 2383, 1590, 1493,
1493, 1101, 973, 808, 696 cm−1 1H NMR (500 MHz, CDCl3) 7.25-7.41
.
(m, 5H), 7.16-7.22 (m, 2H), 6.44-6.52 (m, 2H), 4.60-4.69 (m, 1H), 4.59 (d,
JP-H = 17.02 Hz, 1H), 4.46-4.54 (m, 1H), 1.30 (d, JH-H = 6.15 Hz, 3H),
982, 807, 691 cm−1 1H NMR (500 MHz, CDCl3) 7.70-7.74 (m, 2H),
.
1.28 (d, JH-H = 6.31 Hz, 3H), 1.20 (d, JH-H = 5.99 Hz, 3H), 0.91 (d, JH-H
=
6.15 Hz, 3H), 0.15-0.85 (bm, 3H). 13C NMR (125 MHz, CDCl3) 145.6 (d,
3JP-C = 10.9 Hz, NC), 135.0 (d,2JP-C = 3.6 Hz, C), 131.9 (s, CH), 128.3 (d,
3JP-C = 4.5 Hz, CH), 128.2 (d, 4JP-C = 1.8 Hz, CH), 128.0 (d, 5JP-C = 2.7 Hz,
7.43-7.53 (m, 6H), 7.33-7.36 (m, 2H), 7.27-7.52 (m, 6H), 7.10-7.18 (m,
2H), 7.15-7.20 (m, 2H, minor), 7.10-7.13 (m, 2H, major), 7.01-7.03 (m,
1H, major), 6.99-7.03 (m, 1H, minor), 6.45-6.49 (m, 2H, minor), 6.39-6.40
(m, 2H, major), 4.76 (d, JP-H = 14.19 Hz, 1H, major), 4.73 (d, JP-H = 14.82
Hz, 1H, minor), 4.61-4.68 (m, 1H, minor), 4.39-4.41 (m, 1H, major), 4.02
(bs, 1H), 1.32 (d, JP-H = 6.22 Hz, 3H, minor), 1.23 (d, JH-H = 6.22 Hz, 3H,
minor), 1.16 (d, JH-H = 6.31 Hz, 3H, major), 0.92 (d, JP-H = 6.31 Hz, 3H,
2
CH), 115.4 (s, CH), 110.0 (s, C), 73.8 (d, JP-C = 3.6 Hz, CH), 73,20 (d,
2JP-C = 5.5 Hz, CH), 59.8 (d, 1JP-C = 63.6 Hz, CH), 24.13 (d, 3JP-C = 2.7 Hz,
CH3), 24.10 (d,3JP-C = 2.7 Hz, CH3), 23.7 (d, 3JP-C = 4.5 Hz, CH3), 23.8 (d,
3JP-C = 4.5 Hz, CH3). 31P NMR (202 MHz, CDCl3) 135.95 (bm). HRMS
(ESI/TOF) Found m/z: 410.0887: C19H26BrNO2P ([M-BH3+H]+) requires
m/z: 410.0879. Anal. Calcd for C19H28BrNO2PB: C, 53.81; H, 6.65; N,
3.30. Found: C, 53.90; H, 6.78; N, 3.50.
major), 0.45-0.99 (bm, 6H). 13C NMR (125 MHz, CDCl3) 145.6 (d, JP-C
3
= 10.0 Hz, NC, minor), 145.3 (d, 3JP-C = 11.8 Hz, NC, major), 134.9 (s, C,
major), 134.5 (d, 2JP-C = 3.6 Hz, C, minor), 132.10 (d, 4JP-C = 2.7 Hz, CH,
4
major), 132.06 (d, JP-C = 1.8 Hz, CH, minor), 131.83 (s, CH, minor),
131.76 (s, CH, major), 131.6 (s, C, minor) 131.5 (s, C, major), 131.2 (d,
2JP-C = 10.0 Hz, CH), 131.0 (d, 2JP-C = 10.9 Hz, CH), 130.0 (d, 1JP-C = 59.0
Hz, C), 128.8 (d, JP-C = 3.6 Hz, CH), 128.5 (d, JP-C = 10.5 Hz, CH),
[1-(N-p-Bromophenylamino)]-[1-(p-bromophenyl)methyl]phosphor-
nous acid-borane diisopropyl ester (23b). 22b (0.126 g, 0.25 mmol)
was reacted with BH3-SMe2 (0.237 mL, 2.5 mmol) for 28 h according to
general procedure C to afford 23b (0.107 g, 0.213 mmol, 85) and 24b
(0.0083 g, 0.025 mmol, 10).
3
128.47 (d, JP-C = 3.6 Hz, CH), 128.63 (d, 3JP-C = 10.9 Hz, CH), 128.11 (d,
JP-C = 1.8 Hz, CH), 128.08 (d, JP-C = 2.7 Hz, CH), 128.01 (d, JP-C = 1.8 Hz,
CH), 127.98 (d, JP-C = 1.52 Hz, CH), 127.8 (d, JP-C = 2.7 Hz, CH), 115.6
(s, CH, major), 115.5 (s, CH, minor), 110.3 (s, C, major), 110.1 (s, C,
23b: Colourless oil. Rf = 0.62 (hexane/AcOEt 10:1). IR (ATR, thin film):
.
3403, 2978, 2386, 1487, 972, 810 cm−1 1H NMR (500 MHz, CDCl3)
2
2
minor), 74.3 (d, JP-C = 3.6 Hz, CH, major), 74.2 (d, JP-C = 3.6 Hz, CH,
1
1
minor), 61.1 (d, JP-C = 46.3 Hz, minor), 59.9 (d, JP-C = 49.1 Hz, major),
24.2 (d, 3JP-C = 2.7 Hz, CH3), 24.17 (d, 3JP-C = 4.5 Hz, CH3), 23.6 (d, 3JP-C
= 4.5 Hz, CH3). 31P NMR (202 MHz, CDCl3) 107.53 (bm, major), 111.70
(bm, minor). HRMS (ESI/TOF) Found m/z: 442.1099; C22H27BBrNOP
([M+H]+) requires m/z: 442.1098. Anal. Calcd for C22H26BBrNOP: C,
59.76; H, 5.93; N, 3.17; Found: C, 59.79; H, 5.85; N, 3.10.
7.43-7.47 (m, 2H), 7.25-7.29 (m, 2H), 7.18-7.21 (m, 2H), 6.43-6.46 (m,
2H), 4.72 (bs, 1H), 4.60-4.68 (m, 2H), 4.54 (d, JP-H = 16.55 Hz, 1H), 4.49-
4.58 (m, 1H), 1.30 (d, JH-H = 6.31 Hz, 3H), 1.29 (d, JH-H = 6.15 Hz, 3H),
1.21 (d, JH-H = 6.15 Hz, 3H), 0.99 (d, JH-H = 6.15 Hz, 3H),0.10-0.87 (bm,
3
3H). 13C NMR (125 MHz, CDCl3) 145.2 (d, JP-C = 11.8 Hz, NC), 134.3
2
4
(d, JP-C = 2.7 Hz, C), 131.9 (s, CH), 128.5 (d, JP-C = 1.8 Hz, CH),130.0
3
(d, JP-C = 4.5 Hz, CH), 121.8 (d, 5JP-C = 3.6 Hz, C), 115.4 (s, CH), 110.4
2
2
[(N-4-Bromophenyl)amino](phenyl)methyl]phenylphosphinous acid-
borane ethyl ester (20b). 19b (0.107 g, 0.25 mmol) was reacted with
BH3-SMe2 (71.2 L, 0.75 mmol) for 20 h according to general procedure
C to afford 20b as a mixture of diastereoisomers isolated as a mixture
(0.064 g, 0.15 mmol, 60, dr = 51:49, 31P NMR). An oil. IR (ATR, thin
(s, C), 74.0 (d, JP-C = 3.7 Hz, CH), 73.5 (d, JP-C = 4.9 Hz, CH), 59.4 (d,
1JP-C = 62.7 Hz, CH), 24.12 (d, 3JP-C = 2.7 Hz, CH3), 24.09 (d, 3JP-C = 3.6
3
3
Hz, CH3), 23.8 (d, JP-C = 4.5 Hz, CH3), 23.3 (d, JP-C = 5.4 Hz, CH3).
31P NMR (202 MHz, CDCl3) 134.81 (bm). HRMS (ESI/TOF) Found m/z:
487.9997;C19H25Br2NO2P ([M-BH3]+H+) requires m/z: 487.9984. Anal.
Calcd for C19H27Br2NO2PB: C, 45.37; H, 5.41; N, 2.78; Found: C, 45.50;
H, 5.79; N, 3.00.
film): 3395, 3059, 2384, 1591, 1488, 1042, 810, 692 cm−1 1H NMR (500
.
MHz, CDCl3) 7.69-7.73 (m, 2H); 7.50-7.56 (m, 1H), 7.43-7.50 (m, 4H),
7.28-7.38 (m, 9H), 7.11-7.20 (m, 2H), 7.15-7.19 (m, 2H, minor), 7.11-7.14
(m, 2H, major), 7.01-7.04 (m, 1H, major), 6.90-7.01 (m, 1H, minor), 6.45-
6.49 (m, 2H, minor), 6.38-6.41 (m, 2H, major), 4.94 (bs, 1H), 4.77-4.80
(m, 2H), 4.09-4.18 (m, 1H, minor), 4.00-4.08 (m, 1H, minor), 3.80-3.90 (m,
1H, major), 3.64-3.71 (m, 1H, major), 1.31 (t, JP-H = 7.04 Hz, 3H, minor),
1.14 (t, JP-H = 6.94 Hz, 3H, major), 0.05-1.10 (bm, 6H). 13C NMR (125
24b: 4-bromo-N-(-4-bromobenzyl)aniline.[31] Waxy white solid. Rf
0.45 (hexane/AcOEt 10:1). IR (ATR, solid): 3397, 2390, 1589, 1487,
1010, 810 cm−1 1H NMR (500 MHz, CDCl3) 7.44-7.48 (m, 2H), 7.25-
=
.
7.30 (m, 2H), 7.21-7.25 (m, 2H), 6.51-6.61 (m, 2H), 4.28 (bs, 2H).
13C NMR (125 MHz, CDCl3) 155.1, 138.1, 132.1, 131.8, 129.4, 121.6,
116.0, 48.7. HRMS (ESI/TOF) Found: m/z: 339.9323 C13H12Br2N
([M+H]+) requires m/z: 339.9331.
3
3
MHz, CDCl3) 145.6 (d, JP-C = 10.0 Hz, NC, minor), 145.3 (d, JP-C
=
2
11.8 Hz, NC, major), 134.8 (s, C, major), 134.3 (d, JP-C = 3.6 Hz, C,
minor), 132.3 (d, JP-C = 2.7 Hz, major), 132.2 (d, JP-C = 2.7 Hz, minor),
4
4
13
This article is protected by copyright. All rights reserved.